CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 78 enrolled
Drug / intervention
Reia Vaginal Pessarydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04508335
NCT04508335N/ACompleted

Assessment of Effectiveness and Safety of a Novel Pessary for the Non-Surgical Treatment of Pelvic Organ Prolapse

Reia, LLC·interventional·Posted Aug 11, 2020·Updated Nov 27, 2024

In Brief

A clinical study evaluating Reia Vaginal Pessary for Pelvic Organ Prolapse. Completed, enrolled 78 participants across 7 sites.

Detailed Summary

The purpose of this study is to obtain preliminary data on the effectiveness, safety, function, comfort, and patient satisfaction with a novel vaginal pessary design for the use in women who suffer from symptoms of pelvic organ prolapse (POP) and have already opted for non-surgical management. Recruited patients will have Stage II POP or greater and will be current users of a Gellhorn or ring style pessary. Following enrollment, each subject will enter a 1-month wash out period in which they will continue using their current pessary so that baseline subjective and objective data can be collected. They will then be fit with a study pessary and enter a 3-month treatment phase. Comparative, subjective, and objective data will be collected at the conclusion of the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 11, 2020
Enrollment StartNov 21, 2021
Primary CompletionJun 16, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.9 years ago

Interventions

Reia Vaginal Pessarydevice

Reia Vaginal Pessary